Disruptions of nitric oxide metabolism have been postulated to mediate SSRI-induced sexual disturbances such as erectile dysfunction (R15601CHDDFEFF), and sildenafil may correct the theoretical defects. In addition, some of the SSRI-induced side effects, such as decreased libido and orgasm delay, may be unrelated to nitric oxide metabolism, but sildenafil may enable patients to compensate for these sexual disturbances by improving erections and increasing vasocongestion. Further studies are indicated. Until such time, given the uncertain teratogenic potential, sildenafil should not be prescribed for premenopausal women.